Interferon alfa-2b Terminated Phase 4 Trials for Malignant Lymphomas / Precancerous/Nonmalignant Condition Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00854581Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma